VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO GI 2021 | Alliance A021501: preoperative mFOLFIRINOX +/- hypofractionated RT for pancreatic cancer

Joshua E. Meyer, MD, Fox Chase Cancer Center, Philadelphia, PA, explores some highlights from the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, including the results of the Alliance A021501 study in pancreatic cancer, where the hypofractionated radiotherapy (RT) arm of the study was closed early. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter